Understanding Experimentally Induced Hot Flushes

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 28, 2005

Primary Completion Date

July 24, 2007

Study Completion Date

September 2, 2007

Conditions
Hot Flashes
Interventions
DRUG

Leuprolide acetate

"Leuprolide acetate (Lupron Depot®) 3.75-mg intramuscular injection~Leuprolide is a widely used gonadotropin-releasing hormone agonist (GnRHa) that is indicated for treatment of endometriosis, uterine fibroids, precocious puberty, and prostate cancer, and is used off-label for in-vitro fertilization and premenstrual syndrome. In this protocol, leuprolide will be administered once during the mid-luteal phase of the menstrual cycle at a dose routinely used for treatment of endometriosis and uterine fibroids in women."

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Endocrine Research Society

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00455689 - Understanding Experimentally Induced Hot Flushes | Biotech Hunter | Biotech Hunter